M. Logan

发表

Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus*

N. Kneteman, Anwar Anwar-mohamed, D. Douglas, 2015, The Journal of Biological Chemistry.

Progress toward approval of an HCV vaccine

D. Tyrrell, M. Houghton, M. Logan, 2018, Canadian Liver Journal.

Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes.

D. Tyrrell, M. Houghton, M. Logan, 2017, Vaccine.

Recombinant Hepatitis C Virus Envelope Glycoprotein Vaccine Elicits Antibodies Targeting Multiple Epitopes on the Envelope Glycoproteins Associated with Broad Cross-Neutralization

D. Tyrrell, M. Houghton, R. Belshe, 2014, Journal of Virology.

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

D. Tyrrell, M. Houghton, M. Logan, 2019, Journal of Virology.

Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus

M. Houghton, M. Logan, Julia Koehler Leman, 2017, Journal of Virology.

Progress toward approval of an HCV vaccine.

D. Tyrrell, M. Houghton, M. Logan, 2018, Canadian liver journal.

Effect of Different Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins

D. Tyrrell, M. Houghton, B. Akache, 2019, Vaccines.

No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome

D. Tyrrell, M. Houghton, M. Logan, 2011, PloS one.

SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1

K. Pabbaraju, E. Arutyunova, Justin Shields, 2021, bioRxiv.

Structure and Function of the Hepatitis C Virus Envelope Glycoproteins E1 and E2: Antiviral and Vaccine Targets.

M. Houghton, M. Logan, J. Law, 2016, ACS infectious diseases.

Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis

Zongyi Hu, T. Liang, M. Houghton, 2022, Journal of virology.

Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG

M. Houghton, M. Law, M. Logan, 2016, Journal of Virology.

Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine

D. Tyrrell, M. Houghton, E. Dudek, 2018, Journal of Virology.

Bovine Serum Albumin-Protected Gold Nanoclusters for Sensing of SARS-CoV-2 Antibodies and Virus.

D. Tyrrell, M. Houghton, M. Logan, 2023, ACS applied materials & interfaces.

Utilization of a Glucometer Test Strip and Enzymatic Reactions to Quantify Anti-SARS-CoV-2 Spike RBD IgG Antibody and SARS-CoV-2 Virus in Saliva and Serum

D. Tyrrell, M. Houghton, M. Logan, 2023, Analytical chemistry.

Role of the E2 hypervariable region (HVR1) in the immunogenicity of a 1 recombinant HCV vaccine

M. Houghton, E. Dudek, M. Logan, 2018 .

Functional and immunogenic characterization of diverse HCV glycoprotein E2 variants.

M. Manns, A. Tarr, M. Houghton, 2019, Journal of Hepatology.